多奥米克集成揭示了电针通过肠-大脑轴改善了阿尔茨海默病的认知障碍
Shuai Zhang1, Xinyuan Liu2, Shuyu Xu1
1College of Acupuncture-Moxibustion and Orthopaedics, Hubei University of Chinese Medicine, Wuhan 430061, China.
Biomolecules
|November 27, 2025
概括
电针 (EA) 通过改善肠道微生物群和代谢途径,对阿尔茨海默病 (AD) 产生神经保护作用. 这种非药理学方法为AD治疗提供了一个新的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 微生物学 微生物学
- 代谢学 代谢学 代谢学
背景情况:
- 由于缺乏有效的治疗方法,阿尔茨海默病 (AD) 构成了重大挑战.
- 电针 (EA) 显示出潜在的神经保护益处,但其机制需要阐明.
研究的目的:
- 研究EA在AD中的神经保护作用背后的机制.
- 探索微生物组和代谢组数据的整合,以了解EA对AD的影响.
主要方法:
- 使用老化加速鼠标倾向8 (SAMP8) 模型对AD.
- 进行了EA干预,并进行了16SrRNA测序和血清代谢.
- 将EA治疗的SAMP8小鼠与未治疗的SAMP8和对照SAMR1小鼠进行比较.
主要成果:
- 在AD模型中,EA治疗增强了认知功能,减少了神经元损伤.
- 它调节了肠道微生物群,增加了有益的细菌,减少了有害的细菌.
- EA恢复了代谢途径,特别是 purin 和 phenylpropanoid 代谢,并减少了与特定细菌相关的促炎代谢物.
结论:
- 通过调节肠道微生物群和代谢途径,EA在阿尔茨海默病中发挥神经保护作用.
- EA代表了对AD的有前途的非药物治疗策略.
- 对于计算预测的代谢物-标相互作用,需要进一步的实验验证.
相关概念视频
01:22Alzheimer's Disease: Treatment
772
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
772
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K